Back to Agenda
Using Data Analytics for Good Pharmacovigilance Practices
Session Chair(s)
Kiernan Trevett, MSC
Quality Policy Lead, Genentech, A Member of the Roche Group, United States
This session will consist of perspectives and case studies of how data-driven solutions are being leveraged to support the development of quality assurance strategies for pharmacovigilance activities and to generate quality evidence in relation to Good Pharmacovigilance Practice (GVP) compliance.
Learning Objective : Investigate the use of data-driven solutions to develop quality assurance strategies for Good Pharmacovigilance Practice (GVP) activities and to generate quality evidence in relation to GVP compliance.
Speaker(s)
Industry Update
Principal Quality Data Analyst, Genentech, A Member of the Roche Group, United States
Industry Update
Manager, Pharmacovigilance QA, Janssen Research & Development LLC, United States
Inspector's Perspective
Head of GPvP and Senior Pharmacovigilance Inspector, Medicines and Healthcare products Regulatory Agency (MHRA), United Kingdom
Have an account?